CUSIP 92532F100COMVRTXQ4 2025
85 reported transactions
| # | Date | Insider | Title | Type | Shares | Price | Value | Held After | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Jun 5, 2026 | Bozic Carmen | EVP and CMO | S · Sell | 1.7K | $450.00 | $785.3K | 21.0K | SEC |
| 2 | Jun 1, 2026 | Liu Joy | EVP and Chief Legal Officer | S · Sell | 828 | $439.91 | $364.2K | 20.0K | SEC |
| 3 | May 29, 2026 | Bozic Carmen | EVP and CMO | S · Sell | 2.0K | $450.00 | $888.3K |
See the full Form 4 transaction history for Vertex Pharmaceuticals Inc.
Unlock all transactions| 22.8K |
| SEC |
| 4 | May 15, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | S · Sell | 33 | $453.45 | $15.0K | 7.3K | SEC |
| 5 | May 15, 2026 | Bozic Carmen | EVP and CMO | S · Sell | 1.4K | $453.45 | $614.0K | 24.7K | SEC |
| 6 | May 12, 2026 | Bozic Carmen | EVP and CMO | S · Sell | 7.0K | $450.00 | $3.14M | 26.1K | SEC |
| 7 | May 4, 2026 | Bhatia Sangeeta N. | Director | S · Sell | 318 | $423.73 | $134.7K | 4.9K | SEC |
| 8 | May 1, 2026 | Upadhyay Suketu | Director | D · Disposition | 796 | $0.00 | $0 | 1.6K | SEC |
| 9 | May 1, 2026 | Upadhyay Suketu | Director | A · Grant | 2.9K | $0.00 | $0 | 2.9K | SEC |
| 10 | May 1, 2026 | Upadhyay Suketu | Director | A · Grant | 796 | $0.00 | $0 | 3.6K | SEC |